Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer

Fig. 3

Contribution of key SNV signatures, MNVs, and indels on mutations (left), neoantigens (center), and expressed neoantigens (right). The Chemo category combines the contributions from the chemotherapy signatures. COSMIC signature numbers are in parentheses. The Other SNV category represents SNVs not accounted for by the signatures shown. Bars give the mean, and points indicate individual samples

Back to article page